• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·603882.SS
Share

Guangzhou Kingmed Diagnostics Group Co., Ltd. Stocks

CN¥ 25.18Last Updated 10.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.63B

CN¥ 25.18
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a prominent independent medical laboratory provider. Its extensive service portfolio encompasses a wide array of offerings, such as medical diagnostic information, clinical trial assistance, and comprehensive laboratory services. The company also specializes in food and hygiene testing, health management solutions, and medical cold chain logistics. Additionally, Kingmed engages in scientific research, develops in vitro diagnostics, and utilizes advanced capabilities in healthcare big data, artificial intelligence, and forensic testing. Operating a network of 37 state-of-the-art testing facilities, the company maintains a significant presence across both mainland China and Hong Kong. Established in 2003, its corporate headquarters are situated in Guangzhou, China.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair value on EV/

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.07.2026 15:01

"The 30-Second Rule": How Investors Can Learn to Think Things Through Before Making Trades

12.07.2026 05:26

The U.S. announced a third wave of strikes against Iran following the closure of the Strait of Hormuz

11.07.2026 19:01

A Triumph for City Governments? How China’s Scaling Model Will Change the Global AI Market

11.07.2026 16:01

Highlights from Small-Caps: Royce Fund Forecast, Trump's Sons' Investments, the Chewy Case Study

11.07.2026 15:32

SK Hynix's Record-Breaking IPO: What's Behind the Hype Surrounding Memory Chip Manufacturers

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026